Rolf Gebhardt

University Hospital Leipzig

Papers

1

Total Citations

19

H-Index

1

About

Rolf Gebhardt is a pioneer in hepatic tissue engineering and microfluidic organ-on-chip systems, with a career dedicated to advancing physiologically relevant in vitro liver models. His research centers on developing bioengineered platforms that replicate the complex architecture and metabolic functions of the liver, bridging the gap between traditional cell culture and in vivo biology. His most notable contribution is the HepaChip-MP, a groundbreaking twenty-four chamber microplate featuring continuous, unidirectional perfusion. This microfluidic platform employs automated dielectrophoresis to selectively assemble viable primary human hepatocytes into elongated microtissues, enabling long-term culture and more accurate drug metabolism and toxicity studies. With 19 citations, this work exemplifies his impact in creating scalable, high-throughput tools for preclinical research. Gebhardt’s achievements include advancing liver coculture models that maintain hepatocyte functionality, a critical challenge in the field. His innovative approach has influenced the design of next-generation organ-on-chip devices, making him a key figure in the transition from static to dynamic, microfluidic cell culture systems.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
HepaChip-MP – a twenty-four chamber microplate for a continuously perfused liver coculture model
19 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: University Hospital Leipzig

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago